TipRanks
Medicalgorithmics SA (PL:MDG)
:MDG
Poland Market
MDG
Medicalgorithmics SA
RESEARCH TOOLSreports

Medicalgorithmics SA (MDG) Ratios

1 Followers

Medicalgorithmics SA Ratios

PL:MDG's free cash flow for Q4 2025 was zł0.20. For the 2025 fiscal year, PL:MDG's free cash flow was decreased by zł and operating cash flow was zł-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 ― 1.30 2.49 3.52 5.45
Quick Ratio
 ― 0.88 1.45 2.76 4.60
Cash Ratio
 ― 0.21 0.61 2.07 2.54
Solvency Ratio
 ― -0.15 -0.43 0.06 -0.27
Operating Cash Flow Ratio
 ― -0.14 -1.46 0.01 0.62
Short-Term Operating Cash Flow Coverage
 ― -0.73 -8.84 0.06 1.26
Net Current Asset Value
zł ―zł -29.61Mzł -6.26Mzł 14.16Mzł 27.42M
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.20 0.04 0.05 <0.01
Debt-to-Equity Ratio
 ― 0.35 0.05 0.06 <0.01
Debt-to-Capital Ratio
 ― 0.26 0.05 0.06 <0.01
Long-Term Debt-to-Capital Ratio
 ― 0.24 0.03 0.03 0.04
Financial Leverage Ratio
 ― 1.72 1.37 1.31 1.15
Debt Service Coverage Ratio
 ― -1.50 -7.47 0.57 5.67
Interest Coverage Ratio
 ― -5.60 -101.46 4.01 63.51
Debt to Market Cap
 ― 0.07 0.02 0.04 0.13
Interest Debt Per Share
 ― 2.47 0.43 1.10 0.05
Net Debt to EBITDA
 ― -2.90 0.11 -8.86 -0.88
Profitability Margins
Gross Profit Margin
―-17.95%84.86%39.34%80.30%
EBIT Margin
―-37.02%-65.05%-0.30%40.71%
EBITDA Margin
―-22.04%-49.91%5.19%47.44%
Operating Profit Margin
―-37.02%-68.90%1.00%27.44%
Pretax Profit Margin
―-37.76%-65.73%-0.55%40.28%
Net Profit Margin
―-37.71%-67.00%-1.34%-18.91%
Continuous Operations Profit Margin
―-37.69%-66.99%-1.34%40.62%
Net Income Per EBT
―99.85%101.93%242.86%-46.96%
EBT Per EBIT
―102.01%95.40%-54.97%146.76%
Return on Assets (ROA)
―-10.52%-15.20%-0.48%-10.91%
Return on Equity (ROE)
―-18.08%-20.84%-0.62%-12.53%
Return on Capital Employed (ROCE)
―-11.69%-17.08%0.40%17.48%
Return on Invested Capital (ROIC)
―-11.38%-16.82%0.38%14.62%
Return on Tangible Assets
―-49.11%-58.82%-1.18%-26.47%
Earnings Yield
―-3.49%-9.56%-0.36%-16.97%
Efficiency Ratios
Receivables Turnover
 ― 3.70 3.21 5.13 2.99
Payables Turnover
 ― 6.45 1.50 8.32 5.49
Inventory Turnover
 ― 6.70 0.39 2.80 1.41
Fixed Asset Turnover
 ― 10.56 10.21 18.89 31.31
Asset Turnover
 ― 0.28 0.23 0.35 0.58
Working Capital Turnover Ratio
 ― 3.59 1.08 1.12 2.97
Cash Conversion Cycle
 ― 96.38 814.19 157.45 314.82
Days of Sales Outstanding
 ― 98.53 113.61 71.18 122.21
Days of Inventory Outstanding
 ― 54.44 943.18 130.13 259.14
Days of Payables Outstanding
 ― 56.59 242.60 43.86 66.54
Operating Cycle
 ― 152.97 1.06K 201.31 381.35
Cash Flow Ratios
Operating Cash Flow Per Share
 ― -0.18 -1.31 0.03 1.11
Free Cash Flow Per Share
 ― -0.21 -2.32 -2.11 -1.06
CapEx Per Share
 ― 0.03 1.00 2.14 2.17
Free Cash Flow to Operating Cash Flow
 ― 1.17 1.76 -61.19 -0.95
Dividend Paid and CapEx Coverage Ratio
 ― -5.80 -1.31 0.02 0.51
Capital Expenditure Coverage Ratio
 ― -5.80 -1.31 0.02 0.51
Operating Cash Flow Coverage Ratio
 ― -0.08 -3.16 0.03 703.44
Operating Cash Flow to Sales Ratio
 ― -0.06 -0.54 <0.01 0.10
Free Cash Flow Yield
―-0.64%-13.70%-6.89%-8.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -28.72 -10.43 -279.55 -5.89
Price-to-Sales (P/S) Ratio
 ― 10.79 7.01 3.75 1.11
Price-to-Book (P/B) Ratio
 ― 5.18 2.18 1.75 0.74
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -156.56 -7.30 -14.51 -11.57
Price-to-Operating Cash Flow Ratio
 ― -183.55 -12.86 887.80 11.04
Price-to-Earnings Growth (PEG) Ratio
 ― 1.03 >-0.01 2.95 0.06
Price-to-Fair Value
 ― 5.18 2.18 1.75 0.74
Enterprise Value Multiple
 ― -51.87 -13.93 63.43 1.47
Enterprise Value
 ― 354.25M 166.84M 141.77M 43.74M
EV to EBITDA
 ― -51.87 -13.93 63.43 1.47
EV to Sales
 ― 11.43 6.95 3.29 0.70
EV to Free Cash Flow
 ― -165.85 -7.24 -12.73 -7.24
EV to Operating Cash Flow
 ― -194.43 -12.76 778.94 6.91
Tangible Book Value Per Share
 ― -2.28 -0.13 3.76 2.83
Shareholders’ Equity Per Share
 ― 6.49 7.75 17.50 16.61
Tax and Other Ratios
Effective Tax Rate
 ― <0.01 -0.02 -1.43 >-0.01
Revenue Per Share
 ― 3.11 2.41 8.15 11.00
Net Income Per Share
 ― -1.17 -1.62 -0.11 -2.08
Tax Burden
 ― 1.00 1.02 2.43 -0.47
Interest Burden
 ― 1.02 1.01 1.83 0.99
Research & Development to Revenue
 ― 0.00 0.00 0.02 0.04
SG&A to Revenue
 ― 0.16 0.16 0.31 0.08
Stock-Based Compensation to Revenue
 ― 0.00 0.02 0.00 0.00
Income Quality
 ― 0.16 0.81 -0.31 -0.21
Currency in PLN